[Guillain-Barre syndrome: a study of 13 children]

Area of Science:

• Pediatric Neurology
• Infectious Diseases
• Immunology

Context:

• Guillain-Barré syndrome (GBS) is an autoimmune disorder affecting the peripheral nervous system.
• Pediatric GBS presents unique challenges in diagnosis and management.
• Understanding GBS in children is crucial for effective treatment strategies.

Purpose:

• To retrospectively analyze the clinical features and outcomes of pediatric Guillain-Barré syndrome.
• To identify potential triggers and associated conditions in children with GBS.
• To evaluate the impact of corticosteroid treatment on GBS outcomes in children.

Summary:

• Thirteen children (aged 2-14 years) diagnosed with Guillain-Barré syndrome were studied.
• Preceding infectious illness was noted in 75% of cases, with specific agents identified in four.
• Common symptoms included limb motor deficits, absent reflexes, cranial nerve involvement (46%), and meningitic signs (62%). One patient had Fisher syndrome variant; two required ventilation.
• Associated immunologic abnormalities were present in three children, including selective IgA deficiency, elevated IgE, and Kawasaki syndrome.

Impact:

• This research highlights the diverse clinical presentations of pediatric Guillain-Barré syndrome.
• Findings suggest infectious triggers are common in childhood GBS.
• The study provides insights into the management and outcomes of GBS in a pediatric population, noting no significant difference with corticosteroid use in this cohort.